✦ LIBER ✦

Recombinant interferon-α2b improves immune response to hepatitis B vaccination in haemodialysis patients: Results of a randomised clinical trial

✍ Scribed by María E. Miquilena-Colina; Tamara Lozano-Rodríguez; Leonor García-Pozo; Alicia Sáez; Paola Rizza; Imerio Capone; Maria Rapicetta; Paola Chionne; Maria Capobianchi; Marina Selleri; Concetta Castilletti; Filippo Belardelli; Oreste Lo Iacono; Carmelo García-Monzón

Book ID: 116961814
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 382 KB
Volume: 27
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2009.07.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of different dose levels and vac

Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in haemodialysis patients

✍ M. Bruguera; J.L. Rodicio; J.M. Alcazar; A. Oliver; G. Del Rio; R. Esteban-Mur 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 312 KB

Randomised placebo-controlled trial of r

Randomised placebo-controlled trial of recombinant interleukin-2 in chronic uraemic patients who are non-responders to hepatitis B vaccine

✍ P. Jungers; P. Devillier; H. Salomon; J.E. Cerisier; A.M. Courouce 📂 Article 📅 1994 🏛 The Lancet 🌐 English ⚖ 305 KB

A multicenter randomized controlled tria

A multicenter randomized controlled trial of recombinant interferon-α2b in patients with acute transfusion-associated hepatitis C

✍ Pietro Lampertico; Mariagrazia Rumi; Raffaella Romeo; Antonio Craxi; Roberta Sof 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB 👁 1 views

A randomized controlled clinical trial o

A randomized controlled clinical trial of recombinant interferon α-2b in the treatment of acute post-transfusion hepatitis C: A preliminary report

✍ S-J. HWANG; S-D. LEE; Y-H. W. LEE; J-C. WU; C-Y. CHAN; Y-S. HUANG; Y-J. WANG; K- 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 620 KB

A randomized controlled trial of recombi

A randomized controlled trial of recombinant interferon α-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C

✍ Shinn-Jang Hwang; Shou-Dong Lee; Cho-Yu Chan; Rei-Hwa Lu; Kwang-Juei Lo 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 538 KB

Response to higher doses of interferon a

Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: A randomized multicenter trial

✍ K L Lindsay; G L Davis; E R Schiff; H C Bodenheimer; L A Balart; J L Dienstag; R 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

JANICE ALBRECHT, 12 AND THE HEPATITIS INTERVENTIONAL THERAPY GROUP\* with continued therapy at that dose; however, a propor-To evaluate response rates to 3, 5, or 10 million units tion of patients who do not respond to 12 weeks of treat-(MU) of interferon alfa-2b, given thrice weekly, and to ment wi